NO20081038L - Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering - Google Patents

Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering

Info

Publication number: NO20081038L
Authority: NO; Norway
Prior art keywords: guanfacine; compositions; dosage form; pharmaceutical formulations; single dosage
Prior art date: 2005-07-28

Application number

NO20081038A

Other languages

English (en)

Norwegian (no)

Inventor

Amir Shojaei

Michael Pennick

Original Assignee

Shire Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-28

Filing date

2008-02-27

Publication date

2008-04-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37668083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081038(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-27 Application filed by Shire Llc filed Critical Shire Llc

2008-04-23 Publication of NO20081038L publication Critical patent/NO20081038L/no

Links

INJOMKTZOLKMBF-UHFFFAOYSA-N Guanfacine Chemical group NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl INJOMKTZOLKMBF-UHFFFAOYSA-N 0.000 title abstract 2
229960002048 guanfacine Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 2
239000002552 dosage form Substances 0.000 title 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20081038A 2005-07-28 2008-02-27 Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering NO20081038L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70298205P	2005-07-28	2005-07-28
PCT/US2006/029277 WO2007016284A2 (en)	2005-07-28	2006-07-27	Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily

Publications (1)

Publication Number	Publication Date
NO20081038L true NO20081038L (no)	2008-04-23

Family

ID=37668083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081038A NO20081038L (no)	2005-07-28	2008-02-27	Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering

Country Status (18)

Country	Link
US (1)	US20070048371A1 (pt)
EP (1)	EP1909766B1 (pt)
JP (2)	JP5726401B2 (pt)
KR (1)	KR20080041669A (pt)
CN (1)	CN101252917A (pt)
AR (1)	AR054595A1 (pt)
AU (1)	AU2006275718B8 (pt)
BR (1)	BRPI0615989B8 (pt)
CA (1)	CA2616181C (pt)
DK (1)	DK1909766T3 (pt)
ES (1)	ES2566395T3 (pt)
IL (1)	IL188980A0 (pt)
NO (1)	NO20081038L (pt)
NZ (1)	NZ565649A (pt)
RU (1)	RU2435573C2 (pt)
TW (1)	TW200744672A (pt)
WO (1)	WO2007016284A2 (pt)
ZA (1)	ZA200801575B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0916163D0 (en) *	2009-09-15	2009-10-28	Shire Llc	Prodrugs of guanfacine
US9943489B2 (en) *	2010-02-03	2018-04-17	Pharmatwob Ltd.	Extended release formulations of rasagiline and uses thereof
CN103298455A (zh) *	2010-06-11	2013-09-11	希拉有限责任公司	赖氨酸安非他命与缓释胍法辛的联合治疗
US20120041068A1 (en) *	2010-08-11	2012-02-16	Aptapharma, Inc.	Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility
CN102525983A (zh) *	2010-12-31	2012-07-04	北京万全阳光医药科技有限公司	胍法新缓释片及其制备方法
CN102579381B (zh) *	2012-03-30	2013-07-10	河南中帅医药科技发展有限公司	盐酸胍法辛缓释制剂及其制备方法
WO2014159340A1 (en)	2013-03-13	2014-10-02	Tris Pharma, Inc.	Benzonatate modified release solid tablets and capsules
US10022341B2 (en)	2014-12-02	2018-07-17	Yale University	Methods of preventing neurodegeneration of association cortex in a mammal
MA43402A (fr) *	2015-12-08	2018-10-17	Ardea Biosciences Inc	Composition pharmaceutique comprenant un inhibiteur puissant d'urat1
JP6656670B2 (ja) *	2016-03-11	2020-03-04	国立大学法人鹿児島大学	抗ｈｃｖ活性を有する薬剤
PT3445354T (pt) *	2016-04-20	2022-08-25	New Frontier Labs Llc	Ésteres do ácido azelaico para o tratamento da resistência à insulina
WO2019136224A1 (en) *	2018-01-05	2019-07-11	Shire Human Genetic Therapies, Inc.	Amphetamine-guanfacine combinations for treatment of neuropsychiatric disorders
JP7814869B2 (ja) *	2021-09-01	2026-02-17	東和薬品株式会社	グアンファシン製剤
JP7835098B2 (ja) *	2022-04-15	2026-03-25	ニプロ株式会社	グアンファシン含有徐放性製剤
EP4292587A1 (en)	2022-06-15	2023-12-20	Sawai Pharmaceutical Co., Ltd.	Guanfacine hydrochloride containing pharmaceutical preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH649918A5 (de) *	1981-07-09	1985-06-28	Sandoz Ag	Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie.
IE56999B1 (en) *	1983-12-22	1992-03-11	Elan Corp Plc	Pharmaceutical formulation
US5102668A (en) *	1990-10-05	1992-04-07	Kingaform Technology, Inc.	Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US5854290A (en) *	1995-09-21	1998-12-29	Amy F. T. Arnsten	Use of guanfacine in the treatment of behavioral disorders
DE19834573A1 (de) *	1998-07-31	2000-02-03	Bayer Ag	Doppelmetallcyanid-Katalysatoren für die Herstellung von Polyetherpolyolen
FR2781152B1 (fr) *	1998-07-20	2001-07-06	Permatec Tech Ag	Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
PE20001396A1 (es) *	1999-01-18	2000-12-23	Gruenenthal Chemie	Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
US6635277B2 (en) *	2000-04-12	2003-10-21	Wockhardt Limited	Composition for pulsatile delivery of diltiazem and process of manufacture
US6287599B1 (en) *	2000-12-20	2001-09-11	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DK1355633T3 (da) *	2001-12-19	2005-04-04	Astrazeneca Ab	Ny filmcoating, der indeholder en ethylacrylat/methylmethacrylat-copolymer og polyvinylacetat
US6811794B2 (en) *	2001-12-20	2004-11-02	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE60322371D1 (de) *	2002-03-29	2008-09-04	Alza Corp	Volumensparende arzneiform zur kontrollierten freisetzung
US6763509B2 (en) *	2002-09-26	2004-07-13	Sun Microsystems, Inc.	Method and apparatus for allocating decoupling capacitor cells
US20070104782A1 (en) *	2005-07-28	2007-05-10	Ibrahim Melissa E	Modified release tablet formulations with enhanced mechanical properties

2006
- 2006-07-27 DK DK06788707.5T patent/DK1909766T3/en active
- 2006-07-27 AU AU2006275718A patent/AU2006275718B8/en not_active Expired
- 2006-07-27 CN CNA2006800313902A patent/CN101252917A/zh active Pending
- 2006-07-27 EP EP06788707.5A patent/EP1909766B1/en not_active Expired - Lifetime
- 2006-07-27 ES ES06788707.5T patent/ES2566395T3/es not_active Expired - Lifetime
- 2006-07-27 US US11/493,914 patent/US20070048371A1/en not_active Abandoned
- 2006-07-27 RU RU2008102911/15A patent/RU2435573C2/ru active
- 2006-07-27 WO PCT/US2006/029277 patent/WO2007016284A2/en not_active Ceased
- 2006-07-27 BR BRPI0615989A patent/BRPI0615989B8/pt active IP Right Grant
- 2006-07-27 CA CA2616181A patent/CA2616181C/en not_active Expired - Fee Related
- 2006-07-27 NZ NZ565649A patent/NZ565649A/en unknown
- 2006-07-27 KR KR1020087004755A patent/KR20080041669A/ko not_active Withdrawn
- 2006-07-27 JP JP2008524162A patent/JP5726401B2/ja not_active Expired - Lifetime
- 2006-07-28 TW TW095127856A patent/TW200744672A/zh unknown
- 2006-07-28 AR ARP060103292A patent/AR054595A1/es unknown
2008
- 2008-01-23 IL IL188980A patent/IL188980A0/en unknown
- 2008-02-18 ZA ZA200801575A patent/ZA200801575B/xx unknown
- 2008-02-27 NO NO20081038A patent/NO20081038L/no not_active Application Discontinuation
2012
- 2012-07-17 JP JP2012158337A patent/JP2012229253A/ja active Pending

Also Published As

Publication number	Publication date
TW200744672A (en)	2007-12-16
WO2007016284A3 (en)	2007-03-29
AU2006275718B8 (en)	2012-11-01
RU2435573C2 (ru)	2011-12-10
AU2006275718B2 (en)	2012-10-04
JP5726401B2 (ja)	2015-06-03
US20070048371A1 (en)	2007-03-01
WO2007016284A2 (en)	2007-02-08
CA2616181C (en)	2015-02-17
JP2009502951A (ja)	2009-01-29
BRPI0615989B8 (pt)	2021-05-25
AU2006275718A1 (en)	2007-02-08
AU2006275718A8 (en)	2012-11-01
EP1909766B1 (en)	2016-03-16
NZ565649A (en)	2011-03-31
CN101252917A (zh)	2008-08-27
IL188980A0 (en)	2008-08-07
JP2012229253A (ja)	2012-11-22
CA2616181A1 (en)	2007-02-08
BRPI0615989A2 (pt)	2011-05-31
DK1909766T3 (en)	2016-04-04
ES2566395T3 (es)	2016-04-12
EP1909766A2 (en)	2008-04-16
AR054595A1 (es)	2007-06-27
KR20080041669A (ko)	2008-05-13
BRPI0615989B1 (pt)	2020-05-26
ZA200801575B (en)	2008-12-31
RU2008102911A (ru)	2009-09-10

Legal Events

Date	Code	Title	Description
2010-03-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
AU2008347158A8 (en)	2013-08-22	Oral pharmaceutical dosage forms
MA32200B1 (fr)	2011-04-01	Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
SV2009003231A (es)	2009-11-09	Uso de valerato de estradiol o 17b-estradiol en combinacion con dienogest en una terapia oral para mantener y/o implementar la libido femenina
ECSP10010224A (es)	2010-07-30	Formulaciones líquidas de hormona luteinizante (lh).
ZA200801575B (en)	2008-12-31	Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
UA94942C2 (ru)	2011-06-25	Фармацевтические композиции с ингибиторами dpp iv
CY1115652T1 (el)	2017-01-25	Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
UA106636C2 (uk)	2014-09-25	Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
NO20080220L (no)	2008-04-21	Formuleringer med hoy medikament belastning og doseringsformer
UA116334C2 (uk)	2018-03-12	Тверді форми дозування бендамустину
CY1111442T1 (el)	2015-08-05	Ενωσεις πιπεριδινης και χρησεις αυτων
CR20110704A (es)	2012-06-15	Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
EA201170512A1 (ru)	2011-08-30	Композиция для перорального введения
EP4238556A4 (en)	2024-09-25	GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM
DK1987063T3 (da)	2010-01-04	Peptider og peptidderivater, fremstilling deraf samt deres anvendelse til fremstilling af en terapeutisk og/eller præventivt aktiv farmaceutisk sammensætning
DE602007004348D1 (de)	2010-03-04	Arzneimittel zur behandlung von sarkoglykanopathien
MA31227B1 (fr)	2010-03-01	Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
ATE460934T1 (de)	2010-04-15	Pharmazeutische zubereitungen von ciprofloxacin
EA201290378A1 (ru)	2013-01-30	Композиции, содержащие нестероидные противовоспалительные лекарственные средства
GB0327390D0 (en)	2003-12-31	Pharmaceutical formulations
TR200704897A1 (tr)	2009-02-23	Uzatılmış salım sağlayan gliklazid formülasyonları@
HK40090884A (en)	2023-11-24	Gastroretentive pharmaceutical dosage form
AR070886A1 (es)	2010-05-12	Nuevo regimen de drospirenona /17 beta -estradiol, producto farmaceutico combinado y conjunto de elementos (kit) para su aplicacion
ATE551998T1 (de)	2012-04-15	Feste pharmazeutische zusammensetzung mit tamsulosin